Sorrento Therapeutics Inc. (SRNE) Social Stream
Sorrento Therapeutics Inc (SRNE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Sorrento Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, SRNE's average price target has gone down $5.
SRNE reports an average of 305.64% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SRNE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 30 weeks, SRNE's average broker recommendation rating improved by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SRNE as an investment opportunity.
- In the context of all US stocks, Sorrento Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 394.46% of them.
- SRNE has a greater number of analysts covering the stock than 22.14% of stocks in the mid market cap category.
- SRNE has a higher average analyst price target than 103.41% of stocks in the mid market cap category.
- SRNE has a lower variance in analysts' estimates than -111.51% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Sorrento Therapeutics Inc are SGMO, SANA, and RXRX.
Is SRNE a Buy, Hold or Sell? See the POWR Ratings now!